Ocular Melanoma — Trials

Ocular Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 32
Ph III recruiting: 6
Growth YoY: —
Industry share: 35%
Top sponsor: IDEAYA Biosciences
Termination share: 31.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (36)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00005815	Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma	completed	Phase 1 / Phase 2	—	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 19, 2013	clinicaltrials
NCT00027742	Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma	completed	Phase 2	—	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 5, 2013	clinicaltrials